AFRM vs ZYME · P/E 590, rev $3.22B vs rev $76.3M
Affirm Holdings Inc (AFRM) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the AFRM and ZYME stock pages for the full models.
Not investment advice.